Health Condition 1: R688- Other general symptoms and signs
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Neuranics Lab Pvt. Ltd.
Eligibility
Inclusion criteria
Inclusion criteria: Leftover venous samples and capillary samples collected within four hours.
Exclusion criteria
Exclusion criteria: Specimens which are lysed or clotted specimens. Patients unwilling to sign the consent form and patient information sheet.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between the results of the POCT CBC analyzer (Morph X) and automated traditional analyzer (SYSMEX). The primary outcome is to evaluate the degree of correlation between the results obtained from Morph X and the results obtained from the automated CBC analyzer. The comparison will assess key parameters, such as: oHemoglobin concentration oWBC count oRBC count oRBC indices [MCV, MCH, MCHC, RDW, Hematocrit] oPlatelet count oWBC Differential countTimepoint: Every 4 weeks: 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Precision 2. Sensitivity 3. Reproducibility 4. Matrix comparisonTimepoint: 1. Every 4 weeks: 4, 8, 12, 16, 20, 24, 28, 32, 36, 40, 44, 48 weeks 2. Every 8 weeks: 8, 16, 24, 32, 40, 48 weeks 3. Every 8 weeks: 8, 16, 24, 32, 40, 48 weeks 4. Every 12 weeks: 12, 24, 36, 48 weeks. | — |
Countries
India
Contacts
Public ContactDr Tushar Sehgal
AIIMS, Delhi
Outcome results
None listed